PTPN11 and colorectal carcinoma: Interrogating clinicaltrials.gov databases, several studies involving CRC patients are currently recruiting patients to evaluate allosteric inhibitors of SHP2 (ClinicalTrials.gov Identifiers: NCT04699188, NCT05163028, NCT04252339).